Welcome to MyStrategist, the digital home for MedTech Strategist.

MedTech Strategist, the global medical device industry's most trusted resource, will help you stay ahead of the opportunities and obstacles that are impacting your corporate strategy. We invite you to explore our coverage. Think Strategically. Subscribe Today

Browse   Latest Issue
Latest from MedTech Strategist

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.


Executive Interviews

Stan Lapidus on Diagnostics for Early Cancer Detection

We speak with diagnostics inventor and entreprenuer Stanley Lapidus, who was recently named Vice Chair of PAVmed subsidiary Lucid Diagnostics, which is developing for detecting and treating patients with Barrett’s Esophagus, a precancerous condition that puts people at high risk of esophageal adenocarcinoma cancer.

Trial MyStrategist.com and unlock 7-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways

Start Trial
Latest from MedTech Strategist

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.


Executive Interviews

Stan Lapidus on Diagnostics for Early Cancer Detection

We speak with diagnostics inventor and entreprenuer Stanley Lapidus, who was recently named Vice Chair of PAVmed subsidiary Lucid Diagnostics, which is developing for detecting and treating patients with Barrett’s Esophagus, a precancerous condition that puts people at high risk of esophageal adenocarcinoma cancer.

Don't Just Advertise... Strategize!

Advertise with MedTech Strategist and be seen by medtech's most influential executives.

Learn More
Latest from MedTech Strategist

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.


Update on Cerebral Embolic Protection: Is It Time to Stake Your Claim?

Three CEPD companies have already been acquired by strategics. With the seminal PROTECTED TAVR trial halfway through enrollment, is it time for strategics to place their bets on a small number of private CEPD firms? We interview two candidates with promising next-generation advantages, Transverse Medical and Filterlex Medical.

Discover the opportunities and challenges that impact the global medtech regulatory and reimbursement community with MedTech Strategist Market Pathways.

Subscribe   Free Premier Issue   Learn More
More From MedTech Strategist:

Wearable Technologies: What’s in it for Medical Device Companies?

Healthcare is moving towards a value based payment system, which, in theory, should reward wearable technologies that can measure, coach, and teach patients to keep them healthy and out of the highest cost care settings. But investors and many medical device companies themselves remain skeptical as to the clinical value of wearables, and it is far from clear how they can get paid for their investments in wearable medtech. Some early movers believe they can overcome the burden of proof.

Read Article